Mesa Laboratories, Inc. (MLAB) Stock Grade

About Mesa Laboratories, Inc.'s fundamentals

Mesa Laboratories is a small-cap healthcare specialist with a market capitalization of $744.2 million, currently trading at a P/E ratio of 72.6, which is notably elevated relative to its profitability metrics. The company generated modest revenue growth of 3.4% year-over-year while maintaining a net profit margin of just 2.7%, indicating thin operational profitability despite its high valuation multiple. Return on equity stands at 3.6%, suggesting limited efficiency in converting shareholder capital into earnings, and the company returns only 0.7% in dividend yield to investors.